Production (Stage)
Mind Medicine (MindMed) Inc.
MNMD
$7.79
$0.101.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -17.76% | 40.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.93% | 30.94% | |||
| Operating Income | 0.93% | -30.94% | |||
| Income Before Tax | 32.79% | -153.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 32.79% | -153.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 32.79% | -153.88% | |||
| EBIT | 0.93% | -30.94% | |||
| EBITDA | 0.95% | -30.94% | |||
| EPS Basic | 33.68% | -135.71% | |||
| Normalized Basic EPS | 33.71% | -135.61% | |||
| EPS Diluted | 16.05% | -51.07% | |||
| Normalized Diluted EPS | 35.21% | -142.68% | |||
| Average Basic Shares Outstanding | 1.35% | 7.73% | |||
| Average Diluted Shares Outstanding | 3.76% | 4.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||